- Home
- NMM vs BCRX Comparison
NMM vs BCRX Comparison
Compare NMM & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NMM
- BCRX
- Stock Information
- Founded
- NMM 2007
- BCRX 1986
- Country
- NMM Monaco
- BCRX United States
- Employees
- NMM N/A
- BCRX 531
- Industry
- NMM Marine Transportation
- BCRX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NMM Consumer Discretionary
- BCRX Health Care
- Exchange
- NMM Nasdaq
- BCRX Nasdaq
- Market Cap
- NMM 1.4B
- BCRX 1.5B
- IPO Year
- NMM 2007
- BCRX 1994
- Fundamental
- Price
- NMM $45.34
- BCRX $7.23
- Analyst Decision
- NMM Strong Buy
- BCRX Buy
- Analyst Count
- NMM 1
- BCRX 6
- Target Price
- NMM $80.00
- BCRX $15.17
- AVG Volume (30 Days)
- NMM 128.4K
- BCRX 2.1M
- Earning Date
- NMM 02-11-2025
- BCRX 02-24-2025
- Dividend Yield
- NMM 0.44%
- BCRX N/A
- EPS Growth
- NMM N/A
- BCRX N/A
- EPS
- NMM 13.27
- BCRX N/A
- Revenue
- NMM $1,328,798,000.00
- BCRX $412,579,000.00
- Revenue This Year
- NMM N/A
- BCRX $38.01
- Revenue Next Year
- NMM $15.39
- BCRX $19.04
- P/E Ratio
- NMM $3.44
- BCRX N/A
- Revenue Growth
- NMM N/A
- BCRX 29.92
- 52 Week Low
- NMM $27.47
- BCRX $4.03
- 52 Week High
- NMM $65.89
- BCRX $8.88
- Technical
- Relative Strength Index (RSI)
- NMM 47.87
- BCRX 42.12
- Support Level
- NMM $43.74
- BCRX $7.53
- Resistance Level
- NMM $47.08
- BCRX $8.49
- Average True Range (ATR)
- NMM 1.68
- BCRX 0.42
- MACD
- NMM 0.49
- BCRX -0.02
- Stochastic Oscillator
- NMM 61.93
- BCRX 0.79
About NMM Navios Maritime Partners LP Common Units Representing Limited Partner Interests
Navios Maritime Partners LP is a seaborne shipping company. It owns and operates dry cargo and container vessels with the primary long-term and staggered expiration charters. The firm's fleet consists of Ultra- Handymax, Panamax, Capsize, and Container vessels and categorized in Drybulk and Container vessels. It earns revenue through chartering of vessels, voyage contracts. Geographically, it generates majority revenue from Asia.
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.